EDUARD BOVER

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology MINEOLA, NY NPI 1801831763

General Payments — all program years on this page

$6,929.74

Category: General Payments
Program years: PY2018–2024
Record count: 302
As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,110.58 across 51 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of payment	Amount	Records
Food and Beverage	$1,110.58	51

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entity	Amount	Records
Otsuka America Pharmaceutical, Inc.	$156.82	8
Fresenius USA Marketing, Inc.	$147.46	7
Acerta Pharma LLC	$134.78	6
Bayer HealthCare Pharmaceuticals Inc.	$123.04	6
Amgen Inc.	$104.92	4
Relypsa, Inc.	$101.46	5
Alexion Pharmaceuticals, Inc.	$91.27	3
Ardelyx, Inc.	$48.74	3
ABBVIE INC.	$42.12	2
Retrophin, Inc.	$39.79	2
Lexicon Pharmaceuticals, Inc.	$29.18	1
Boehringer Ingelheim Pharmaceuticals, Inc.	$26.92	1
NOVARTIS PHARMACEUTICALS CORPORATION	$25.82	1
Takeda Pharmaceuticals U.S.A., Inc.	$23.33	1
E.R. Squibb & Sons, L.L.C.	$14.93	1

By program year

Program year	Amount	Records
2018	$1,098.29	48
2019	$904.42	34
2020	$655.08	37
2021	$886.70	35
2022	$1,178.34	50
2023	$1,096.33	47
2024	$1,110.58	51

Records — PY2024 (51)

Record ID	Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Source
1081718272	Lexicon Pharmaceuticals, Inc.	$29.18	05/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086172100	Bayer Healthcare Pharmaceuticals Inc.	$25.89	02/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086176374	Bayer Healthcare Pharmaceuticals Inc.	$21.24	04/02/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086196652	Bayer Healthcare Pharmaceuticals Inc.	$18.09	11/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086217311	Bayer Healthcare Pharmaceuticals Inc.	$16.72	02/20/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086225508	Bayer Healthcare Pharmaceuticals Inc.	$18.23	09/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086233286	Bayer Healthcare Pharmaceuticals Inc.	$22.87	05/28/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1086752175	Novartis Pharmaceuticals Corporation	$25.82	10/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1093942005	Alexion Pharmaceuticals, Inc.	$27.81	12/03/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1094023489	Alexion Pharmaceuticals, Inc.	$37.97	06/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1094036607	Alexion Pharmaceuticals, Inc.	$25.49	09/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1101228335	E.R. Squibb & Sons, L.L.C.	$14.93	08/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1103355128	ABBVIE INC.	$23.69	05/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1103355130	ABBVIE INC.	$18.43	10/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104356829	AstraZeneca Pharmaceuticals LP	$25.79	12/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104445441	AstraZeneca Pharmaceuticals LP	$22.09	12/16/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104475928	AstraZeneca Pharmaceuticals LP	$23.40	02/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1104669523	AstraZeneca Pharmaceuticals LP	$21.03	04/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105257871	AstraZeneca Pharmaceuticals LP	$21.30	01/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1105654950	AstraZeneca Pharmaceuticals LP	$21.17	05/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111534518	Amgen Inc.	$21.22	04/22/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111534520	Amgen Inc.	$29.27	08/26/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1111534522	Amgen Inc.	$19.51	04/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1117207949	Amgen Inc.	$34.92	08/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118161038	Boehringer Ingelheim Pharmaceuticals, Inc.	$26.92	05/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865575	Otsuka America Pharmaceutical, Inc.	$22.12	02/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865577	Otsuka America Pharmaceutical, Inc.	$5.93	02/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865579	Otsuka America Pharmaceutical, Inc.	$21.46	04/08/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865581	Otsuka America Pharmaceutical, Inc.	$23.66	05/13/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865583	Otsuka America Pharmaceutical, Inc.	$24.56	06/10/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865585	Otsuka America Pharmaceutical, Inc.	$20.20	07/01/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865587	Otsuka America Pharmaceutical, Inc.	$17.17	08/05/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1118865589	Otsuka America Pharmaceutical, Inc.	$21.72	09/09/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124037361	Vifor Pharma, Inc.	$17.24	03/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124043969	Vifor Pharma, Inc.	$18.32	05/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124044198	Vifor Pharma, Inc.	$23.06	01/16/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124056432	Vifor Pharma, Inc.	$21.17	07/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1124067734	Vifor Pharma, Inc.	$21.67	11/12/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1137494084	Takeda Pharmaceuticals U.S.A., Inc.	$23.33	06/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146672386	Ardelyx, Inc.	$16.06	05/07/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146672388	Ardelyx, Inc.	$15.44	07/23/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1146672390	Ardelyx, Inc.	$17.24	09/25/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149941391	Travere Therapeutics, Inc.	$13.24	12/17/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1149941395	Travere Therapeutics, Inc.	$26.55	11/19/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154202702	Fresenius USA Marketing, Inc.	$2.42	08/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154202704	Fresenius USA Marketing, Inc.	$22.24	08/06/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154202706	Fresenius USA Marketing, Inc.	$23.44	10/15/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154202708	Fresenius USA Marketing, Inc.	$24.67	01/23/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154202710	Fresenius USA Marketing, Inc.	$24.71	05/21/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154202712	Fresenius USA Marketing, Inc.	$24.85	04/30/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS
1154202714	Fresenius USA Marketing, Inc.	$25.13	02/27/2024	Food and Beverage	Undisputed	01/23/2026	View at CMS

Provenance & corrections

Dataset: CMS Open Payments — General Payments
Source: CMS Open Payments dataset (bulk file)
Publisher of source data: Centers for Medicare & Medicaid Services
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.